^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
bbT369
i
Other names: bbT369
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Regeneron
Drug class:
CD20-targeted CAR-T immunotherapy, CD79a-targeted CAR-T immunotherapy
Related drugs:
